
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+7
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications
Biocatalysis,directed evolution,enzyme optimization,biocatalysts,enzyme engineering,life sciences,enzyme replacement therapy,api manufacturing,pharmaceutical manufacturing,rna manufacturing,rna detection,and oligo synthesis
Codexis, inc operates in the Biotechnology research industry.
Codexis, inc's revenue is 11m - 100m
Codexis, inc has 201 - 500 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.